A new clinical trial in the UK has established a minimum age of 11 for children to participate in studies involving puberty-blocking medications. This development specifically targets gender-questioning youth.
A new clinical trial in the UK has established a minimum age of 11 for children to participate in studies involving puberty-blocking medications. This development specifically targets gender-questioning youth.